• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 21VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Unspecified Infection (1930); Pericardial Effusion (3271)
Event Date 04/21/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 21mm sjm masters series valsalva aortic valved graft was implanted.No concomitant cardiac procedures were performed during the same surgery.There were no intraprocedural adverse events or device deficiencies recorded.On 14 march 2023, a computed tomography (ct) scan was performed which revealed fluid and air inclusion in sternal, retrosternum, and aortic root.Patient had pericardial effusion, mediastinitis, retrosternal hematoma, and retrosternal infection.This was believed to be related to patient's history of a wound healing disorder.Patient was started on antibiotics.There was macroscopically suspected hematoma infection with contact to the graft, and no bacteria was isolated.There were no direct signs of a graft infection.Hospitalization was prolonged.On ct scan, the sternum appeared to be stable.On (b)(6) 2023, patient had resternotomy performed with pleural and pericardial drainage.During reopening, some sternal fractures were observed.On 04 april 2023, the patient was discharged from the hospital.On 21 april 2023, the patient returned with sternal instability and was re-hospitalized.It was reported that there was no allegation against the abbott device, and the implanted valved graft was still working as intended.
 
Manufacturer Narrative
An event of pericardial effusion, mediastinitis, retrosternal hematoma, and retrosternal infection was reported.A returned device assessment could not be performed as the device was not returned for analysis.Information from the field indicated that the reported event was believed to be related to patient's history of a wound healing disorder.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met specifications.Based on the information received, the cause of the reported incident could not be conclusively determined but could be related to the patient's medical history.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16950401
MDR Text Key315440693
Report Number2135147-2023-02157
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009478
UDI-Public05414734009478
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2023
Device Model Number21VAVGJ-515
Device Catalogue Number21VAVGJ-515
Device Lot Number6951865
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/13/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
Patient SexFemale
Patient Weight72 KG
Patient RaceWhite
-
-